Antibiotice Iasi Predicts Lower Revenue, Lower-Than-Expected Operating Margins For 2025 Fiscal Year
Jan 22, 2026
Antibiotice Iasi Predicts Lower Revenue, Lower-Than-Expected Operating Margins For 2025 Fiscal Year.
Romanian-owned drug producer Antibiotice Iasi (stock symbol: ATB) published the preliminary data regarding the key performance indicators for the 2025 fiscal year, which show weaker results than its initial estimations.
[Read the article in Ziarul Financiar]